Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 460 participants.

Also called NCT06660940

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 460 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06660940
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06660940. Randomized; quadruple masking; primary purpose treatment. Start 2024-10 (anticipated); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy
Condition
Diabetic Kidney Disease
Condition
Diabetic Retinopathy
Intervention (Drug)
Keluoxin Capsules
Intervention (Drug)
Keluoxin Capsule Simulants
Intervention (Drug)
Irbesartan
Lead sponsor
Chinese PLA General Hospital (class: other)

Record details

Record id
cardio:ct-nct06660940
Content hash
0f105bc403a0df5c371ce6e049e2accf95bea15c8f70d750da1dae4dd813bd05